Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...

Millions of us take vitamins, minerals, and other supplements daily to improve our health and well-being—but taking certain ...

The U.S. Food and Drug Administration has expanded its approval of Spravato, an antidepressant nasal spray. The drug is now ...

The Food and Drug Administration (FDA) has approved Spravato, a nasal spray developed by Johnson & Johnson, as a standalone ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

Following U.S. FDA Priority Review, approval is based on data demonstrating SPRAVATO® alone met its primary endpoint at 4 weeks and led to rapid and superior improvement in depressive symptoms ...

Pristiq (desvenlafaxine) and Effexor (venlafaxine) are SNRIs. Pristiq treats depression, while Effexor treats depression and ...

But many people who take daily medications are unaware that certain drugs in their pill box can also increase their risk of ...

Explore the differences between a psychiatrist and a therapist, and how each specialist can help improve your mental health ...

As the winter skies become gray and cloud-covered, the winds blow, snow grows by the foot, and the temperatures dip in this two-peninsula state, a portion of Michigan’s 10 million residents face ...

This paper reviews recent findings on the pharmacogenetics of antidepressant drugs and future clinical applications. Ultimately, these studies should lead to the use of genetic testing to guide ...